drugset / Trial / NCT03652779

A Study to Evaluate the Safety and Tolerability of Tecarfarin in Healthy Chinese Volunteers

NCT03652779

Phase 1 Completed 40 enrolled Lee's Pharmaceutical Limited
Non-randomizedSequentialOpen-labelBasic science

Summary

The purpose of the study is to evaluate the safety and tolerability of a single dose of tecarfarin in healthy Chinese Volunteers. the Pharmacokinetic and pharmacodynamic profile of tecarfarin will also be evaluated.

Timeline

Start
2018-06-22
Primary completion
2019-10-28
Completion
2019-10-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Tecarfarin Small molecule 10 mg
Subject Tecarfarin Small molecule 20 mg
Subject Tecarfarin Small molecule 30 mg
Subject Tecarfarin Small molecule 40 mg

Indications

No indication recorded.